Skip to main content
Premium Trial:

Request an Annual Quote

Elan Pharmaceuticals Joins GeneGo's MetaTox Consortium

NEW YORK (GenomeWeb News) - Elan Pharmaceuticals has joined the MetaTox Consortium, a group spearheaded by informatics firm GeneGo that aims to address the reasons behind the failure of investigational drugs in clinical trials.
 
GeneGo said the consortium includes members from industry and the US Food and Drug Administration and will focus on using systems biology tools and informatics to assess the safety of small molecule compounds and therapeutics.
 
The group will focus its efforts on developing predictive models, increasing toxicity knowledge, and developing data analysis software for use in systems biology, GeneGo said.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.